CSF3 and neoplasm: Several studies also identify tumor-derived CSF3 (also known as G-CSF) as a cytokine that recruits myeloid cells to the TME, and CSF3 is associated with T cell inhibition and desensitization of PDAC tumors to immunotherapy (22, 32, 45).